Strides Arcolab is currently trading at Rs. 921.65, up by 15.45 points or 1.70% from its previous closing of Rs. 906.20 on the BSE.
The scrip opened at Rs. 919.15 and has touched a high and low of Rs. 940.00 and Rs. 857.95 respectively. So far 32,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 958.10 on 10-Sep-2012 and a 52 week low of Rs. 295.10 on 19-Sep-2011.
Last one week high and low of the scrip stood at Rs. 958.10 and Rs. 857.95 respectively. The current market cap of the company is Rs. 5,400 crore.
The promoters holding in the company stood at 28.27% while Institutions and Non-Institutions held 54.03% and 17.70% respectively.
Agila specialties (Agila), injectables unit of Strides Arcolab (Strides) has received US FDA approval for its Polish Sterile facility .The state - of- the art facility located in Warsaw, Poland, manufactures vials, ampoules, pre- filled syringes and lyophilized injections.
Shipments from the polish facility will commence within Q4’ 2012 and will run in full capacity by Q1’ 2013, as product transfers have already commenced.
With this approval all eight global sterile injectable sites of Agila are now approved by the US FDA and EU. The authorities now place Agila amongst the largest global capacities for sterile injectables.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1568.85 |
Dr. Reddys Lab | 6536.00 |
Cipla | 1509.40 |
Zydus Lifesciences | 1162.40 |
Lupin | 1769.40 |
View more.. |